- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Value of Medicines
- Research
- About
PDUFA V
The reauthorization of the Prescription Drug User Fee Act (PDUFA V) will help advance drug development and review, ultimately helping patients access safe and effective new medicines faster. It will help drive medical innovation and economic growth by bringing greater certainty, predictability and efficiency to the FDA's drug review process.
